Carboprost tromethamine (carboprost tromethamine)
(carboprost tromethamine)Xellia Pharmaceuticals USA LLC
Usage: Carboprost tromethamine injection is indicated for aborting pregnancies between the 13th and 20th weeks and for treating postpartum hemorrhage due to uterine atony unresponsive to conventional management. It addresses fetal expulsion failures and specific complications during second-trimester abortions and helps control severe bleeding after childbirth.